ConductScience.org, home

Gene · 407014

MIR25: microRNA 25

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR25: microRNA 25. Genes, record 407014. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/407014

On this page

Gene

Symbol
MIR25
HGNC
Name
microRNA 25
HGNC
NCBI Gene ID
407014
NCBI Gene
HGNC ID
HGNC:31609
HGNC
Ensembl
ENSG00000207547
NCBI Gene
Aliases
MIRN25, hsa-mir-25, miR-25
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,360

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR25 papersNewest fiscal year
P30CA016672Cancer Center Support Grant152025
P30CA016058Cancer Center Support Grant82025
P30CA054174Mays Cancer Center at UT Health SA62025
ZIAAG000393Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging52025
P30CA033572Cancer Center Support Grant42025
P30DK084567Mayo Center for Cell Signaling in Gastroenterology42025
R01CA178441Combinatorial epigenetic-based prevention of breast cancer42025
ZIAAG000394Post-transcriptional regulation of energy usage: glucose and lipid metabolism42025
I01BX001733Regulation of calcium homeostasis in the pancreatic beta cell32025
P30CA068485Cancer Center Support Grant32025

1 to 10 of 1,360Source NIH's project files

See all 1,360 nih grants

Papers3,611

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Diagnostic and Prognostic Roles of Blood-Based Immune Biomarkers in Non-Small Cell Lung Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses.Life (Basel)202642514200PubTator, text miningPubMed
Epigenetic Regulation Involving microRNAs in Diabetes.Biomolecules202642194090PubTator, text miningPubMed
Network-based analysis reveals potential microRNA regulation of oncogenic pathways in SOX10-depleted uveal melanoma.Cell Mol Life Sci202642120529PubTator, text miningPubMed
Sex-dependent salivary microRNA expression profiles and psychophysiological responses to acute stress in healthy adults.Psychoneuroendocrinology202642013779PubTator, text miningPubMed
Integrated spatial transcriptomics and pan-cancer XGBoost modeling uncover spatial drivers of immune exclusion and predict immunotherapy response.Cancer Immunol Immunother202641925746PubTator, text miningPubMed
SMR Peptide Modulates Tumor-Derived Extracellular Vesicles microRNA and Inflammatory Transcript Signatures in TNBC.Cells202641892339PubTator, text miningPubMed
Advancements in nanobiosensors for early cancer detection, challenges, treatment, and future prospects: a comprehensive review.Discov Nano202641874885PubTator, text miningPubMed
Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review).Int J Oncol202641860028PubTator, text miningPubMed
Exploratory Analysis of MicroRNA (miRNA) as a Prognostic and Predictive Biomarker in Locally Advanced and Metastatic Gastric Cancer.Cureus202641815612PubTator, text miningPubMed
Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications.Front Immunol202641798919PubTator, text miningPubMed

1 to 10 of 3,611

See all 3,611 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/407014

GET https://conductscience.org/api/genes/v1/407014/grants?page=2